e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Modulating the immune system in COPD and asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The utility of HLA-DQB302 as a genetic marker to predict the effect of aspirin desensitization on lung function of patients with aspirin exacerbated respiratory disease
Zahra Aryan (Tehran, Islamic Republic of Iran), Zahra Aryan, Hossein Esmaeilzadeh, Ali Akbar Amirzargar, Mohammad Nabavi
Source:
International Congress 2015 – Modulating the immune system in COPD and asthma
Session:
Modulating the immune system in COPD and asthma
Session type:
Poster Discussion
Number:
3611
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Zahra Aryan (Tehran, Islamic Republic of Iran), Zahra Aryan, Hossein Esmaeilzadeh, Ali Akbar Amirzargar, Mohammad Nabavi. The utility of HLA-DQB302 as a genetic marker to predict the effect of aspirin desensitization on lung function of patients with aspirin exacerbated respiratory disease. Eur Respir J 2015; 46: Suppl. 59, 3611
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
The effects of standard therapy for COPD patients on FEV1 are associated with lower score of the Goddard classification
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Correlation among functional respiratory parameters and disease control in asthma
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015
Assessment the dependence between nutritional status and functional damage of the lungs as well as prognosis in BODE index in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Small airway dysfunction is associated to the excessive bronchoconstriction in asthma
Source: International Congress 2014 – Lung function testing: new findings and new approaches
Year: 2014
Correlation of nutritional status using subjective global assessment (SGA) on pulmonary function parameters in patients with COPD at the Philippine Heart Center
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Lung function impairment in adult asthma increases the risk of systemic inflammation
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Bronchodilator response of advanced lung function parameters depending on COPD severity
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Determination of the existence of a correlation between lung function decline and changes in the COPD assessment test
Source: International Congress 2014 – Clinical presentations
Year: 2014
Genetic influences on lung function decline in AATD
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015
The effects of bronchodilators on regional lung sound distribution in patients with COPD
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Use of CARAT® and pulmonary function tests to assess asthma control during pregnancy
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
Inhaled beta-agonist does not modify sympathetic activity in patients with COPD
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
The [bdquo]frequent exacerbator“ phenotype: Endothelial dysfunction and functional status
Source: International Congress 2014 – Multidimensional analysis of respiratory problems
Year: 2014
Impulse oscillometry assessment of small airway dysfunction pre- and post-bronchodilator in asthma and its relationship to disease severity
Source: International Congress 2014 – Alterations of exercise and lung function in different diseases
Year: 2014
Lung function indices versus symptoms for monitoring the course of the disease in patients with COPD
Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates
Year: 2008
Functional and immunological abnormalities in patients with severe asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Positive bronchodilator response is a poor predictor of future risk in well controlled asthma patients
Source: International Congress 2016 – Functional assessment of the airways
Year: 2016
Impact of lung function impairment and exacerbation history on COPD patient-reported utility
Source: International Congress 2014 – COPD markers
Year: 2014
Lung clearance index is increased in patients with COPD
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept